WASHINGTON – A genetically engineered animal for human consumption was approved by U.S. regulators for the first time, allowing AquaBounty Technologies Inc. to begin marketing its faster-growing salmon — a creation critics have dubbed “Frankenfish.”
The Food and Drug Administration cleared AquAdvantage Salmon, which has added genes that allows the fish to more quickly expand to produce more flesh. It’s a victory for AquaBounty after a two-decade struggle to be able to sell the animal to farmers.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.